Figure 5
Figure 5. Domain-dependent impairment of RUNX1 and p300 phosphorylation by leukemogenic PEBP2-β-SMMHC fusion protein. (A) Determination of regions within PEBP2-β-SMMHC necessary for the repression of p300 phosphorylation. Wild-type PEBP2-β or deletion variants of PEBP2-β-SMMHC fusion proteins were coexpressed in HEK293 cells with RUNX1 and FLAG-p300. Western blot analyses were performed using the indicated antibodies. (B) Schematic diagrams depicting different PEBP2-β-SMMHC deletion constructs used in panel A. The region delineated to be important in the inhibition of RUNX1 phosphorylation is also indicated.

Domain-dependent impairment of RUNX1 and p300 phosphorylation by leukemogenic PEBP2-β-SMMHC fusion protein. (A) Determination of regions within PEBP2-β-SMMHC necessary for the repression of p300 phosphorylation. Wild-type PEBP2-β or deletion variants of PEBP2-β-SMMHC fusion proteins were coexpressed in HEK293 cells with RUNX1 and FLAG-p300. Western blot analyses were performed using the indicated antibodies. (B) Schematic diagrams depicting different PEBP2-β-SMMHC deletion constructs used in panel A. The region delineated to be important in the inhibition of RUNX1 phosphorylation is also indicated.

Close Modal

or Create an Account

Close Modal
Close Modal